Search

everythinglearnresearchcommunity

for

Search:↓

MESTSV is a rare tumor that is mostly benign but needs long-term monitoring due to potential recurrence.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Epidermal nevi are skin cell clusters linked to various syndromes.

Stem cell vesicles can reduce skin aging from UVB by lowering inflammation and oxidative stress.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

Bio-Pulsed sEVs improve hair growth and skin rejuvenation.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

A new genetic variant causes BRESHECK syndrome by disrupting cell growth and stress response.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

Mutations in the ACTB gene cause Becker’s nevi and may lead to muscle issues in Becker’s nevus syndrome.

Electrical impedance spectroscopy improves biopsy accuracy and efficiency for skin lesions.

Longer treatment with vismodegib lowers relapse risk in basal cell carcinoma.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Platelet-derived exosomes offer better regenerative therapy but face challenges in isolation and regulation.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Ellis van Creveld syndrome, a rare genetic disorder, can cause unexpected abnormalities in various body organs, requiring thorough patient evaluations.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Stem cell-derived vesicles improve blood vessel growth in limbs.

Extracellular vesicles show promise as treatments but need more research for safety and effectiveness.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

A hospital outbreak of catheter infections in calves was caused by a bacteria from a beef herd, leading to longer hospital stays, more drug use, and calf deaths.

EV-based therapies are advancing but need to overcome challenges for full potential.

Sonidegib and vismodegib have different side effects and reporting patterns.

Promising cancer treatments were found, but the manufacturer closed.